Skip to main content
eScholarship
Open Access Publications from the University of California

UC San Diego

UC San Diego Previously Published Works bannerUC San Diego

The FDA approval of pembrolizumab for adult and pediatric patients with tumor mutational burden (TMB) ≥10: a decision centered on empowering patients and their physicians.

  • Author(s): Subbiah, V
  • Solit, DB
  • Chan, TA
  • Kurzrock, R
  • et al.
Main Content
Current View